Torella, Daniele
 Distribuzione geografica
Continente #
AS - Asia 1.769
SA - Sud America 594
NA - Nord America 577
EU - Europa 170
AF - Africa 70
AN - Antartide 1
Totale 3.181
Nazione #
SG - Singapore 728
US - Stati Uniti d'America 523
BR - Brasile 423
VN - Vietnam 351
CN - Cina 275
HK - Hong Kong 165
AR - Argentina 63
FR - Francia 60
KR - Corea 53
BD - Bangladesh 36
MX - Messico 27
IQ - Iraq 24
CO - Colombia 22
ZA - Sudafrica 22
EC - Ecuador 21
VE - Venezuela 20
IN - India 19
RU - Federazione Russa 17
DE - Germania 16
ID - Indonesia 15
PK - Pakistan 15
CL - Cile 14
MA - Marocco 14
PY - Paraguay 12
UA - Ucraina 12
IT - Italia 11
GB - Regno Unito 10
NL - Olanda 10
FI - Finlandia 8
PL - Polonia 8
SA - Arabia Saudita 8
AZ - Azerbaigian 7
OM - Oman 7
TN - Tunisia 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
KE - Kenya 6
MY - Malesia 6
PE - Perù 6
UY - Uruguay 6
BO - Bolivia 5
CR - Costa Rica 5
DO - Repubblica Dominicana 5
IL - Israele 5
JO - Giordania 5
NI - Nicaragua 5
PH - Filippine 5
TR - Turchia 5
CA - Canada 4
KZ - Kazakistan 4
AL - Albania 3
DZ - Algeria 3
ET - Etiopia 3
JP - Giappone 3
LB - Libano 3
PS - Palestinian Territory 3
SY - Repubblica araba siriana 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
CY - Cipro 2
EG - Egitto 2
ES - Italia 2
IR - Iran 2
KG - Kirghizistan 2
LT - Lituania 2
LU - Lussemburgo 2
LY - Libia 2
PA - Panama 2
SN - Senegal 2
TG - Togo 2
AM - Armenia 1
AQ - Antartide 1
BB - Barbados 1
BH - Bahrain 1
BZ - Belize 1
CH - Svizzera 1
CI - Costa d'Avorio 1
GF - Guiana Francese 1
GH - Ghana 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
IE - Irlanda 1
JM - Giamaica 1
LK - Sri Lanka 1
MD - Moldavia 1
MG - Madagascar 1
NG - Nigeria 1
NP - Nepal 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
Totale 3.181
Città #
Singapore 243
San Jose 177
Hong Kong 165
Ho Chi Minh City 131
Hefei 91
Beijing 77
Ashburn 72
Hanoi 71
Dallas 55
Lauterbourg 55
Seoul 53
São Paulo 31
Phoenix 23
Da Nang 17
Haiphong 16
Los Angeles 16
Rio de Janeiro 15
Curitiba 12
Biên Hòa 11
Amsterdam 10
Boardman 10
Hillsboro 10
Orem 10
Brasília 9
Shanghai 9
Belo Horizonte 8
Quito 8
Santa Clara 8
Baku 7
Boston 7
Guayaquil 7
Hải Dương 7
Johannesburg 7
Santiago 7
Warsaw 7
Baghdad 6
Brooklyn 6
Bến Tre 6
Medellín 6
New York 6
Tashkent 6
Tianjin 6
Amman 5
Barquisimeto 5
Bogotá 5
Campinas 5
Caracas 5
Casablanca 5
Charlotte 5
Dhaka 5
Formosa 5
Frankfurt am Main 5
Guarulhos 5
Managua 5
Mexico City 5
Nairobi 5
Recife 5
San Miguel de Tucumán 5
Buenos Aires 4
Bắc Giang 4
Chennai 4
Córdoba 4
Fortaleza 4
Guangzhou 4
Helsinki 4
Kuala Lumpur 4
Lima 4
Montevideo 4
Muscat 4
Nha Trang 4
Ninh Bình 4
Porto Alegre 4
Ribeirão das Neves 4
Seattle 4
Tây Ninh 4
Addis Ababa 3
Anaheim 3
Asunción 3
Atlanta 3
Belgorod 3
Can Tho 3
Cape Town 3
Chicago 3
Erbil 3
Falkenstein 3
Francisco Morato 3
Ha Long 3
Jakarta 3
Jundiaí 3
La Plata 3
Lahore 3
Lấp Vò 3
Manaus 3
Maringá 3
Meknes 3
Nova Iguaçu 3
Phủ Lý 3
Ponta Grossa 3
Quảng Ngãi 3
Quận Ba 3
Totale 1.727
Nome #
Biological properties and regenerative potential, in vitro and in vivo, of human cardiac stem cells isolated from each of the four chambers of the adult human heart 83
Administration of a Loading Dose Has No Additive Effect on Platelet Aggregation During the Switch From Ongoing Clopidogrel Treatment to Ticagrelor in Patients With Acute Coronary Syndrome 83
Carbonic Anhydrase Activation Is Associated With Worsened Pathological Remodeling in Human Ischemic Diabetic Cardiomyopathy 81
Cardiac stem and progenitor cell identification: Different markers for the same cell? 75
Atrial myxomas arise from multipotent cardiac stem cells 73
Avoidance of a Reload During the Therapeutic Shift From Clopidogrel to Ticagrelor in Patients With Acs Has No Influence on Residual Platelet Reactivity 72
Will Artificial Intelligence Provide Answers to Current Gaps and Needs in Chronic Heart Failure? 72
Corrigendum to: The everlasting dispute between coronary bypass and angioplasty in patients with multivessels coronary artery disease: results of the SYNTAX II study 72
Cardiac stem cell ablation worsens cardiac remodeling and increases mortality after diffuse myocardial damage in rats 70
8-chloro-cAMP inhibits smooth muscle cell proliferation in vitro and neointima formation induced by balloon injury in vivo 69
Combining cell and gene therapy to advance cardiac regeneration 69
Routine invasive strategy does not reduce major cardiac events in patients with acute coronary syndromes without ST elevation 69
Cardiac stem and progenitor cell biology for regenerative medicine 67
Aspiration Thrombectomy: an easily forgiven "latecomer" 65
Endogenous cardiac stem cell activation by insulin-like growth factor-1/hepatocyte growth factor intracoronary injection fosters survival and regeneration of the infarcted pig heart 63
Diagnostic performance of iFR for the evaluation of Left Main Coronary Artery Stenoses 62
The use and abuse of Cre/Lox recombination to identify adult cardiomyocyte renewal rate and origin 62
HMGA1 is a novel candidate gene for myocardial infarction susceptibility 60
diaGnostiC perFormanCe oF iFr For evalUation oF intermediate leFt main Coronary artery stenoses 59
Adult cardiac stem cells are multipotent and robustly myogenic: c-kit expression is necessary but not sufficient for their identification 58
Erratum. miRNA Regulation of the Hyperproliferative Phenotype of Vascular Smooth Muscle Cells in Diabetes. Diabetes 2018;67:2554-2568 58
Cardiac stem cell-based myocardial regeneration: towards a translational approach 57
UTILITÀ DELLA DETERMINAZIONE DEGLI INDICI DI SHEAR STRESS MEDIANTE FLUIDODINAMICA COMPUTAZIONALE IN PAZIENTI CON STENOSI CORONARICA 57
PKA-activated p85alpha prevents neointimal hyperplasia after balloon endothelial denudation without impairing endothelial regeneration 57
Effects of balloon injury on neointimal hyperplasia in streptozotocin-induced diabetes and in hyperinsulinemic nondiabetic pancreatic islet-transplanted rats 56
Adult c-kitpos Cardiac Stem Cells Are Necessary and Sufficient for Functional Cardiac Regeneration and Repair 56
Vitamin D Binding protein antagonism inhibits vascular smooth muscle cell proliferation while promotes endothelial cell growth in vitro 56
How do cardiologists select patients for dual antiplatelet therapy continuation beyond 1 year after a myocardial infarction? Insights from the EYESHOT Post-MI Study 54
Response to Letter Regarding, "Administration of a Loading Dose Has No Additive Effect on Platelet Aggregation During the Switch From Ongoing Clopidogrel Treatment to Ticagrelor in Patients With Acute Coronary Syndrome" 54
Serum proteomics identifies vitamin D-Binding protein and prothrombin as novel fingerprints of coronary thrombosis in patients with STEMI 54
Kitcre knock-in mice fail to fate-map cardiac stem cells 53
Senolytics rejuvenate aging cardiomyopathy in human cardiac organoids 53
Instantaneous wave-Free Ratio (iFR) and Gradient (iFG): new promising adenosine-independent alternative to fractional flow reserve. Preliminary results from the FORECAST Study 52
In vitro CSC-derived cardiomyocytes exhibit the typical microRNA-mRNA blueprint of endogenous cardiomyocytes 51
The present and future of drug-eluting stents 49
Intracoronary Versus Intravenous Abciximab Bolus Administration 49
Gene therapy for restenosis after balloon angioplasty and stenting 47
Increased vascular endothelial growth factor expression but impaired vascular endothelial growth factor receptor signaling in the myocardium of type 2 diabetic patients with chronic coronary heart disease 47
Left radial access for percutaneous coronary procedures: From neglected to performer? A meta-analysis of 14 studies including 7603 procedures 46
The everlasting dispute between coronary bypass and angioplasty in patients with multivessels coronary artery disease: Results of the SYNTAX II study 45
Spontaneous Regression of Subocclusive Coronary Stenosis: Does Time Heals All Wounds? 44
The administration of a loading dose has no additive effect on platelet aggregation during the switch from ongoing clopidogrel treatment to ticagrelor in patients with Acute Coronary Syndrome 43
Molecular effects of HMG-CoA reductase inhibitors on smooth muscle cell proliferation 43
Low-dose anticoagulation after isolated mechanical aortic valve replacement with Liva Nova Bicarbon prosthesis: A post hoc analysis of LOWERING-IT Trial 42
Neointimal proliferation is associated with clinical restenosis 2 years after fully bioresorbable vascular scaffold implantation 41
Mediterranean jellyfish sting-induced Tako-Tsubo cardiomyopathy 41
Genetically modified animal models to study cardiovascular disorders 40
Re-broken and remended male heart 39
Proteomic serum analysis identifies an increase of vitamin D binding protein 39
miRNA Regulation of the Hyperproliferative Phenotype of Vascular Smooth Muscle Cells in Diabetes 38
OFFgel-based multidimensional LC-MS/MS approach to the cataloguing of the human platelet proteome for an interactomic profile 38
Event reduction after intracoronary versus intravenous abciximab in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a meta-analysis of clinical trials 38
Resting Pressure Gradient (iFG) Instantaneous Wave-free ratio (iFR) for Non-culprit Stenosis Evaluation in Patients with Acute Coronary Syndromes. Preliminary Data from the FORECAST Study 38
The Role of Mitochondrial Dynamics in Cardiovascular Diseases 37
Membrane-bound protein kinase A inhibits smooth muscle cell proliferation in vitro and in vivo by amplifying cAMP-protein kinase A signals 37
Novel basic science insights to improve the management of heart failure: Review of the working group on cellular and molecular biology of the heart of the italian society of cardiology 37
Generation of new cardiomyocytes after injury: de novo formation from resident progenitors vs. replication of pre-existing cardiomyocytes 36
Migration of a stent from left main and its retrieval from femoral artery: A case report 35
LOWERing the INtensity of oral anticoaGulant Therapy in patients with bileaflet mechanical aortic valve replacement: results from the "LOWERING-IT" Trial 35
What accounts for the higher clinical efficacy of intracoronary abciximab? 34
Intracoronary abciximab reduces death and major adverse cardiovascular events in acute coronary syndromes: a meta-analysis of clinical trials 33
Totale 3.243
Categoria #
all - tutte 13.255
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.255


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202414 0 0 0 0 0 0 6 0 2 0 0 6
2024/2025734 3 10 1 1 5 139 51 59 53 63 52 297
2025/20262.495 376 129 195 264 535 201 251 142 203 199 0 0
Totale 3.243